These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 15967445)

  • 1. Downregulation of Ski and SnoN co-repressors by anisomycin.
    Vázquez-Macías A; Ruíz-Mendoza AB; Fonseca-Sánchez MA; Briones-Orta MA; Macías-Silva M
    FEBS Lett; 2005 Jul; 579(17):3701-6. PubMed ID: 15967445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SnoN co-repressor binds and represses smad7 gene promoter.
    Briones-Orta MA; Sosa-Garrocho M; Moreno-Alvarez P; Fonseca-Sánchez MA; Macías-Silva M
    Biochem Biophys Res Commun; 2006 Mar; 341(3):889-94. PubMed ID: 16442497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downregulation of SnoN oncoprotein induced by antibiotics anisomycin and puromycin positively regulates transforming growth factor-β signals.
    Hernández-Damián J; Tecalco-Cruz AC; Ríos-López DG; Vázquez-Victorio G; Vázquez-Macías A; Caligaris C; Sosa-Garrocho M; Flores-Pérez B; Romero-Avila M; Macías-Silva M
    Biochim Biophys Acta; 2013 Nov; 1830(11):5049-58. PubMed ID: 23872350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Role of Ski/SnoN protein in the regulation of TGF-beta signal pathway].
    Lu ZH; Chen J
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Apr; 25(2):233-6. PubMed ID: 12905729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ski and SnoN: negative regulators of TGF-beta signaling.
    Luo K
    Curr Opin Genet Dev; 2004 Feb; 14(1):65-70. PubMed ID: 15108807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Ski and SnoN: antagonistic proteins of TGFbeta signaling].
    Vignais ML
    Bull Cancer; 2000 Feb; 87(2):135-7. PubMed ID: 10705283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. c-Ski inhibits the TGF-beta signaling pathway through stabilization of inactive Smad complexes on Smad-binding elements.
    Suzuki H; Yagi K; Kondo M; Kato M; Miyazono K; Miyazawa K
    Oncogene; 2004 Jun; 23(29):5068-76. PubMed ID: 15107821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance of the expression of c-Ski and SnoN, possible mediators in TGF-beta resistance, in primary cutaneous melanoma.
    Boone B; Haspeslagh M; Brochez L
    J Dermatol Sci; 2009 Jan; 53(1):26-33. PubMed ID: 18782659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inability of transforming growth factor-beta to cause SnoN degradation leads to resistance to transforming growth factor-beta-induced growth arrest in esophageal cancer cells.
    Edmiston JS; Yeudall WA; Chung TD; Lebman DA
    Cancer Res; 2005 Jun; 65(11):4782-8. PubMed ID: 15930298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulation of Smad transcriptional corepressors SnoN and Ski in the fibrotic kidney: an amplification mechanism for TGF-beta1 signaling.
    Yang J; Zhang X; Li Y; Liu Y
    J Am Soc Nephrol; 2003 Dec; 14(12):3167-77. PubMed ID: 14638915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Actin-cytoskeleton polymerization differentially controls the stability of Ski and SnoN co-repressors in normal but not in transformed hepatocytes.
    Caligaris C; Vázquez-Victorio G; Sosa-Garrocho M; Ríos-López DG; Marín-Hernández A; Macías-Silva M
    Biochim Biophys Acta; 2015 Sep; 1850(9):1832-41. PubMed ID: 26002202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of the constitutive complex formation of c-Ski/SnoN with Smads in the impaired negative feedback regulation of transforming growth factor beta signaling in scleroderma fibroblasts.
    Jinnin M; Ihn H; Mimura Y; Asano Y; Tamaki K
    Arthritis Rheum; 2007 May; 56(5):1694-705. PubMed ID: 17469184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two short segments of Smad3 are important for specific interaction of Smad3 with c-Ski and SnoN.
    Mizuide M; Hara T; Furuya T; Takeda M; Kusanagi K; Inada Y; Mori M; Imamura T; Miyazawa K; Miyazono K
    J Biol Chem; 2003 Jan; 278(1):531-6. PubMed ID: 12426322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nuclear and cytoplasmic c-Ski differently modulate cellular functions.
    Nagata M; Goto K; Ehata S; Kobayashi N; Saitoh M; Miyoshi H; Imamura T; Miyazawa K; Miyazono K
    Genes Cells; 2006 Nov; 11(11):1267-80. PubMed ID: 17054724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Smad7 expression on metastasis of mouse mammary carcinoma JygMC(A) cells.
    Azuma H; Ehata S; Miyazaki H; Watabe T; Maruyama O; Imamura T; Sakamoto T; Kiyama S; Kiyama Y; Ubai T; Inamoto T; Takahara S; Itoh Y; Otsuki Y; Katsuoka Y; Miyazono K; Horie S
    J Natl Cancer Inst; 2005 Dec; 97(23):1734-46. PubMed ID: 16333029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The transforming activity of Ski and SnoN is dependent on their ability to repress the activity of Smad proteins.
    He J; Tegen SB; Krawitz AR; Martin GS; Luo K
    J Biol Chem; 2003 Aug; 278(33):30540-7. PubMed ID: 12764135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Up-regulated transcriptional repressors SnoN and Ski bind Smad proteins to antagonize transforming growth factor-beta signals during liver regeneration.
    Macias-Silva M; Li W; Leu JI; Crissey MA; Taub R
    J Biol Chem; 2002 Aug; 277(32):28483-90. PubMed ID: 12023281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downregulation of SnoN expression in obstructive nephropathy is mediated by an enhanced ubiquitin-dependent degradation.
    Tan R; Zhang J; Tan X; Zhang X; Yang J; Liu Y
    J Am Soc Nephrol; 2006 Oct; 17(10):2781-91. PubMed ID: 16959829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytoplasmic SnoN in normal tissues and nonmalignant cells antagonizes TGF-beta signaling by sequestration of the Smad proteins.
    Krakowski AR; Laboureau J; Mauviel A; Bissell MJ; Luo K
    Proc Natl Acad Sci U S A; 2005 Aug; 102(35):12437-42. PubMed ID: 16109768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of melanoma inhibitory activity on transforming growth factor-beta signaling in malignant melanoma.
    Rothhammer T; Bosserhoff AK
    Melanoma Res; 2006 Aug; 16(4):309-16. PubMed ID: 16845326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.